French PE Firm Says Its Offer Price For UK's Instem Is Firm
Health care investment firm Archimed SAS said Friday that it will not increase the £203 million ($247 million) price it has offered to take British life sciences software business Instem PLC...To view the full article, register now.
Already a subscriber? Click here to view full article